Type 1 Diabetes: A Chronic Anti-Self-Inflammatory Response

Area of Science:

• Immunology
• Endocrinology
• Autoimmunity

Background:

• Inflammation is a normal immune response to infection, usually resolved afterward.
• Autoimmunity occurs when the immune system mistakenly attacks the body's own tissues, leading to chronic inflammation.
• Type 1 diabetes (T1D) is an autoimmune disease where T cells target and destroy insulin-producing beta cells in the pancreas.

Purpose of the Study:

• To review the key events that initiate and sustain T cell-driven pancreatic islet inflammation in T1D.
• To examine the mechanisms underlying the loss of tolerance and the development of autoimmune responses against beta cells.
• To discuss findings from both nonobese diabetic mouse models and human T1D studies.

Main Methods:

• This review synthesizes existing research on T cell-mediated autoimmunity in T1D.
• It analyzes genetic and environmental factors influencing immune tolerance.
• It discusses the roles of effector T cells (Teff) and regulatory T cells (Tregs) in islet inflammation.

Main Results:

• Dysregulation of thymic selection and peripheral tolerance contributes to T1D pathogenesis.
• Intrinsic and extrinsic factors promote the expansion and pathogenicity of beta cell-specific Teff cells.
• Defects in the homeostasis and suppressor function of FoxP3-expressing regulatory T cells impair immune control.
• Beta cell properties can also contribute to the inflammatory environment within the islets.

Conclusions:

• Chronic inflammation, sustained by aberrant T cell responses, characterizes T1D autoimmunity.
• Understanding these mechanisms is crucial for developing targeted therapies to halt beta cell destruction and preserve insulin production.